Spironolactone responsive familial hypertension. A potentially high prevalence of mineralocorticoid disease in Oman

Nicholas J., Woodhouse; Omiema T., El Shaie; Ali, Mehar; W.J., Johnston; M., Al Kaabi

Nicholas J., Woodhouse; Omiema T., El Shaie; Ali, Mehar; W.J., Johnston; M., Al Kaabi.

Saudi Medical Journal. 2003; 24 (2): 229-31

in English | IMEMR | ID: emr-64556

Subject(s)

Humans; Male; Female; Hypertension/drug therapy; Spironolactone; Prevalence; Mineralocorticoids; Antihypertensive Agents; Hyperaldosteronism; Adrenal Hyperplasia, Congenital

Search on Google

XML

Index: IMEMR (Eastern Mediterranean) Main subject: Spironolactone / Prevalence / Adrenal Hyperplasia, Congenital / Hyperaldosteronism / Hypertension / Mineralocorticoids / Antihypertensive Agents Type of study: Prevalence study Limits: Female / Humans / Male Language: English Journal: Saudi Med. J. Year: 2003

Similar

MEDLINE

LILACS

LIS

Search on Google

XML